Academic literature on the topic 'Relapse'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Relapse.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Relapse"

1

Wudhikarn, Kitsada, Pinyo Rattanaumpawan, and Margarida M. Silverman. "Characterization of Extramedullary Relapse After Allogeneic Stem Cell Transplant in Acute Myeloblastic Leukemia: Distinct Entity and Outcome." Blood 120, no. 21 (2012): 1972. http://dx.doi.org/10.1182/blood.v120.21.1972.1972.

Full text
Abstract:
Abstract Abstract 1972 Introduction: Relapse after allogeneic stem cell transplant (SCT) is a major cause of morbidity and mortality of acute myeloblastic leukemia (AML) patients. Most relapses primarily involve bone marrow whereas extramedullary (EM) relapses are relatively uncommon. Data on natural history, optimal management and treatment outcome in EM relapse following allogeneic SCT are limited. Method: We retrospectively reviewed 130 AML patients who underwent allogeneic SCT at the University of Iowa Hospitals and Clinics between January 2003 and December 2010. Pre-transplant baseline ch
APA, Harvard, Vancouver, ISO, and other styles
2

Wang, Yucai, Umar Farooq, Brian K. Link, et al. "Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy." Journal of Clinical Oncology 37, no. 21 (2019): 1819–27. http://dx.doi.org/10.1200/jco.19.00014.

Full text
Abstract:
PURPOSE In patients with diffuse large B-cell lymphoma (DLBCL), most relapses occur within the first 2 years of diagnosis. We sought to define the rate and outcome of late relapses that occurred after achieving event-free survival at 24 months (EFS24). METHODS We prospectively followed 1,324 patients with newly diagnosed DLBCL from 2002 to 2015 and treated with immunochemotherapy. Cumulative incidences of late DLBCL and indolent lymphoma relapses were analyzed as competing events. Postrelapse survival was defined as time from first relapse to death from any cause. RESULTS In 847 patients who a
APA, Harvard, Vancouver, ISO, and other styles
3

Ganzel, Chezi, Wang Xin Victoria, Adele K. Fielding, et al. "in Philadelphia-Chromosome-Negative Acute Lymphoblastic Leukemia, Late Relapses Are Not Uncommon, Occur Mostly in Patients at Standard Risk and Have a Relatively Favorable Outcome. Results of the International ALL Trial: MRC Ukallxii/ECOG E2993." Blood 126, no. 23 (2015): 795. http://dx.doi.org/10.1182/blood.v126.23.795.795.

Full text
Abstract:
Abstract This study was coordinated by the ECOG-ACRIN Cancer Research Group (Robert L. Comis, MD and Mitchell D. Schnall, MD, PhD, Group Co-Chairs) and the Medical Research Counsel, United Kingdom, and supported in part by Public Health Service Grants CA180820, CA180794, CA180790, CA189859, CA180853, CA180791, and from the National Cancer Institute, National Institutes of Health and the Department of Health and Human Services. Its content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute. Background: Late relapse
APA, Harvard, Vancouver, ISO, and other styles
4

Platte, Victoria, Anika Bergmann, Barbara Hildebrandt, et al. "Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component." Cancers 14, no. 24 (2022): 6244. http://dx.doi.org/10.3390/cancers14246244.

Full text
Abstract:
An improved understanding of relapse kinetics is required to optimize detection and treatment strategies for the post-transplant relapse of myeloid neoplasms. Therefore, we retrospectively analyzed data from 91 patients allografted for MDS (n = 54), AML-MRC (n = 29) and chronic myelomonocytic leukemia (CMML, n = 8), who relapsed after transplant. Patients with early (<12 months, n = 56) and late relapse (>12 months, n = 35) were compared regarding patient-, disease- and transplant-related factors, including karyotype analyses at diagnosis and relapse. After a median follow-up of 17.4 mon
APA, Harvard, Vancouver, ISO, and other styles
5

Stolpa, Weronika, Magdalena Zapała, Bartosz Zwiernik, and Agnieszka Mizia-Malarz. "Relapses Children’s Acute Lymphoblastic Leukemia, Single Center Experience." Children 9, no. 12 (2022): 1874. http://dx.doi.org/10.3390/children9121874.

Full text
Abstract:
The prognosis in children and adolescents with relapsed ALL, despite intensive therapy, including hematopoietic stem cell transplantation, is still challenging. This study aims to analyze the incidence of relapsed ALL and survival rates in correlation to the risk factors. Materials and methods: 125 pediatric patients with ALL diagnosed in our department between 2000-2018; age 1–18 years old (median 6.4); female 53.6 % vs. male 46.4 %. Results: 19 pts (15.2%) were diagnosed with a relapse. Three pts (15.8%) had been diagnosed with very early relapses (2/3 T-ALL), 12 pts (63.1%) as an early rela
APA, Harvard, Vancouver, ISO, and other styles
6

Nagane, Motoo, Nobuyoshi Sasaki, Yuki Yamagaishi, Kuniaki Saito, Keiichi Kobayashi, and Hirofumi Nakatomi. "CTNI-81. REAL-WORLD TREATMENT RESULTS OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TREATED BY MEDICAL THERAPIES." Neuro-Oncology 25, Supplement_5 (2023): v96—v97. http://dx.doi.org/10.1093/neuonc/noad179.0363.

Full text
Abstract:
Abstract Recurrence of primary central nervous system lymphoma (PCNSL) is a condition which often leads to morbidity and mortality. Consensus regarding the optimal treatment regimen for relapsed PCNSL has not been achieved due to the rarity of the disease. In this study, we conducted a retrospective, single-institution study to investigate real world treatment results of relapsed PCNSL treated by several medical therapeutic regimens. Relapsed PCNSL patients treated at the authors’ institution were identified, and progression-free survival (PFS), overall survival (OS) were analyzed among patien
APA, Harvard, Vancouver, ISO, and other styles
7

Barz, Malwine J., Jana Hof, Stefanie Groeneveld-Krentz, et al. "Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia." Blood 135, no. 12 (2020): 921–33. http://dx.doi.org/10.1182/blood.2019002499.

Full text
Abstract:
Abstract Activating mutations in cytosolic 5′-nucleotidase II (NT5C2) are considered to drive relapse formation in acute lymphoblastic leukemia (ALL) by conferring purine analog resistance. To examine the clinical effects of NT5C2 mutations in relapsed ALL, we analyzed NT5C2 in 455 relapsed B-cell precursor ALL patients treated within the ALL-REZ BFM 2002 relapse trial using sequencing and sensitive allele-specific real-time polymerase chain reaction. We detected 110 NT5C2 mutations in 75 (16.5%) of 455 B-cell precursor ALL relapses. Two-thirds of relapses harbored subclonal mutations and only
APA, Harvard, Vancouver, ISO, and other styles
8

Abu Shanap, Mayada, and Iyad Sultan. "Outcome of Relapsed Childhood Acute Lymphoblastic Leukemia in Resource-Poor Country : Warrants the Need for Immunotherapy." Blood 144, Supplement 1 (2024): 5857. https://doi.org/10.1182/blood-2024-206147.

Full text
Abstract:
Introduction: The overall survival (OS) rate for children with acute lymphoblastic leukemia (ALL) treated at King Hussein Cancer Center is approximately 80%, aligning with published results of the Total XV regimen. Method: From December 2003 until August 2023, children/adolescents (<18 years at diagnosis) with ALL in first and subsequent relapses were studied. Treatment of relapse consisted of reinduction regimens followed by intensive continuation therapy and hematopoietic stem cell transplantation (HSCT) in selected patients. The poor prognostic group (PPG) included patients who did n
APA, Harvard, Vancouver, ISO, and other styles
9

Maxwell, Rebecca, Beate Häberle, Roland Kappler, et al. "Hepatoblastoma Relapse—Findings from the German HB99 Trial and the German Liver Tumor Registry." Cancers 16, no. 4 (2024): 696. http://dx.doi.org/10.3390/cancers16040696.

Full text
Abstract:
Survival rates for HB patients have improved; however, outcomes for patients who relapse remain poor. A retrospective review of information gathered for the HB99 study and the German Liver Tumor Registry identified 25 relapse patients (6.9%, 25/362). The median time from initial diagnosis to first relapse was 13 months (range: 5–66 months). Two patients relapsed >36 months after initial diagnosis. A total of 68% (17/25) of relapses were metastatic, 24% local, and 8% combined. 67% of local relapses were alive at the last follow-up, in contrast to 53% of metastatic and 0% of combined relapses
APA, Harvard, Vancouver, ISO, and other styles
10

Hill, Rebecca, Stacey Richardson, Edward Schwalbe, et al. "MBRS-44. TIME, PATTERN AND OUTCOME OF MEDULLOBLASTOMA RELAPSE ARE ASSOCIATED WITH TUMOUR BIOLOGY AT DIAGNOSIS AND UPFRONT THERAPY: A COHORT STUDY." Neuro-Oncology 22, Supplement_3 (2020): iii405—iii406. http://dx.doi.org/10.1093/neuonc/noaa222.553.

Full text
Abstract:
Abstract Disease relapse occurs in ~30% of children with medulloblastoma, and is fatal in the majority. We sought to establish whether clinico-molecular characteristics at diagnosis are associated with the nature of relapse, subsequent disease-course, and whether these associations could inform clinical management. We surveyed the clinical features of medulloblastoma relapse (time-to-relapse, pattern-of-relapse, time-to-death and overall outcome) in 247 centrally-reviewed patients who relapsed following standard-upfront-therapies. We related these to clinico-molecular features at diagnosis, pr
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Relapse"

1

Agboola, Shade. "Smoking relapse prevention : abstinence, relapse, current practice and effective interventions." Thesis, University of Nottingham, 2017. http://eprints.nottingham.ac.uk/43623/.

Full text
Abstract:
Smoking remains a major cause of morbidity and mortality. In 2013/2014, 454,700 hospital admissions in the UK amongst persons 35 years and over were estimated to be attributable to smoking. This accounts for 4 per cent of all hospital admissions in this age group. In 2013, 17% (78,200) of all deaths in adults aged 35 and over were estimated to be caused by smoking[1]. Reducing smoking therefore, remains a major priority for governments and health systems like the UK National Health Service (NHS). Following the publication of the Government’s White Paper, Smoking Kills[2] in 1998, a comprehensi
APA, Harvard, Vancouver, ISO, and other styles
2

Malkus, Amy J. "Relapse Prevention Manual." Digital Commons @ East Tennessee State University, 2002. https://dc.etsu.edu/etsu-works/4700.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Caravati, Paula Ciavarella. "Obesity Relapse in Women." Diss., Virginia Tech, 2001. http://hdl.handle.net/10919/26817.

Full text
Abstract:
Obesity and relapse after dieting pose a significant threat to an increasing number of adults in this country. Resistance to treatment and high relapse rates make this problem frustrating for patients and practitioners. There is limited research on relapse causation; research on social and life circumstance factors is uncommon. Given the limitations of existing research, the purpose of this study was to investigate the natural course of obesity relapse. A purposive sample of eight obese women, ages 31-57, was selected. All of the women relapsed at least one or more times throughout their li
APA, Harvard, Vancouver, ISO, and other styles
4

Klein, Jeffery Lane. "Attributional style and alcoholic relapse /." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 1997. http://wwwlib.umi.com/cr/ucsd/fullcit?p9804031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bowersox, Nicholas W. "Treatment Attrition and Relapse Readmission in Psychiatric Inpatients: Predictors of Treatment Engagement and Psychiatric Relapse." [Milwaukee, Wis.] : e-Publications@Marquette, 2009. http://epublications.marquette.edu/dissertations_mu/18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Paseman, Wallace W. "Relapse Prevention Using Mobile Electronic Media." Thesis, State University of New York Empire State College, 2017. http://pqdtopen.proquest.com/#viewpdf?dispub=10278346.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Morrison, Fraser. "Predictors of relapse in alcohol dependence." Thesis, University of Edinburgh, 2008. http://hdl.handle.net/1842/24999.

Full text
Abstract:
Relapse rates following treatment for alcohol dependence are high, and efforts to prevent relapse are an integral part of treatment. Outcome studies have reported relapse rates of 65% within one year of treatment, with the majority relapsing within less than three months. Many factors have been studied as potential predictors of relapse in alcohol dependence, such as psychiatric disorder. Fifty four residents in an inpatient alcohol detoxification unit were tested on measures of memory and executive functioning, mood, self efficacy, quality of life, and liver function at the end of a seven to
APA, Harvard, Vancouver, ISO, and other styles
8

Ramo, Danielle Elizabeth. "Developmental models of substance abuse relapse." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 2008. http://wwwlib.umi.com/cr/ucsd/fullcit?p3297587.

Full text
Abstract:
Thesis (Ph. D.)--University of California, San Diego and San Diego State University, 2008.<br>Title from first page of PDF file (viewed April 28, 2008). Available via ProQuest Digital Dissertations. Vita. Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
9

Byrne, Susan Mary. "Weight maintenance and relapse in obesity." Thesis, University of Oxford, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.393355.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gumley, Andrew Ian. "Psychological aspects of relapse in schizophrenia." Thesis, University of Stirling, 2002. http://hdl.handle.net/1893/12115.

Full text
Abstract:
Following a review of the relevant literature a Cognitive Behavioural treatment protocol for the prevention of relapse in schizophrenia is presented. This treatment protocol is investigated in a 12-month non-blind randomised controlled trial comparing Cognitive Behavioural Therapy and Treatment as Usual (CBT + TAU) versus Treatment as Usual (TAU) alone. Three studies of treatment outcome are described: relapse and admission, remission and social functioning, and psychological distress. 144 participants with a DSM-IV Schizophrenia spectrum disorder were randomised to receive either CBT + TAU (n
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Relapse"

1

Abuse, National Institute on Drug. Introducing relapse prevention. National Institutes of Health ; National Institute on Drug Abuse, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Turner, Nikki. Relapse: A novel. One World Trade Paperbacks-Ballantine Books, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

National Institute on Drug Abuse. Introducing relapse prevention. National Institutes of Health ; National Institute on Drug Abuse, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

National Institute on Drug Abuse. Introducing relapse prevention. National Institutes of Health ; National Institute on Drug Abuse, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Richards, C. Steven, and Michael G. Perri, eds. Relapse prevention for depression. American Psychological Association, 2010. http://dx.doi.org/10.1037/12082-000.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jon, Carlson, American Psychological Association, and Governors State University. Division of Digital Learning and Media Design, eds. Relapse prevention over time. American Psychological Association, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1948-, Gossop Michael, ed. Relapse and addictive behaviour. Tavistock/Routledge, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Richards, C. Steven. Relapse prevention for depression. American Psychological Association, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Steven, Richards C., Perri Michael G, and American Psychological Association, eds. Relapse prevention for depression. American Psychological Association, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Association, American Psychological, ed. Relapse prevention for depression. American Psychological Association, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Relapse"

1

Lustyk, M. Kathleen B., and Gabriana Navarrete. "Relapse, Relapse Prevention." In Encyclopedia of Behavioral Medicine. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_276.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Molina, Kristine M., Kristine M. Molina, Heather Honoré Goltz, et al. "Relapse, Relapse Prevention." In Encyclopedia of Behavioral Medicine. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_276.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lustyk, M. Kathleen B., and Gabriana Navarrete. "Relapse, Relapse Prevention." In Encyclopedia of Behavioral Medicine. Springer New York, 2020. http://dx.doi.org/10.1007/978-1-4614-6439-6_276-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Melemis, Steven M. "Relapse and Relapse Prevention." In Alcohol Use: Assessment, Withdrawal Management, Treatment and Therapy. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-18381-2_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Floresco, Stan, Robert Kessler, Ronald L. Cowan, et al. "Relapse." In Encyclopedia of Psychopharmacology. Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_544.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Erb, Suzanne, and Franca Placenza. "Relapse." In Animal Models of Drug Addiction. Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-934-5_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Milhorn, H. Thomas. "Relapse." In Substance Use Disorders. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-63040-3_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bruijn, Brian D., and Lucy L. Bruijn. "Relapse." In Working with the Human Trafficking Survivor. Routledge, 2019. http://dx.doi.org/10.4324/9781315684468-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hsu, Sharon Hsin, and G. Alan Marlatt. "Addiction syndrome: Relapse and relapse prevention." In APA addiction syndrome handbook, Vol. 2: Recovery, prevention, and other issues. American Psychological Association, 2012. http://dx.doi.org/10.1037/13750-005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

O’Hara, Peggy. "Relapse Prevention." In The Clinical Management of Nicotine Dependence. Springer New York, 1991. http://dx.doi.org/10.1007/978-1-4613-9112-8_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Relapse"

1

Tripathi, Mukesh Kumar, Meka Ananya, V. N. L. N. Murthy, Tumma Shashank, Jale Subash Reddy, and Kaushal Attaluri. "Enhanced Breast Cancer Relapse Prediction using Ensemble Learning Techniques." In 2024 4th International Conference on Sustainable Expert Systems (ICSES). IEEE, 2024. https://doi.org/10.1109/icses63445.2024.10763119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Khatri, Radhika, Faryal Khan, and Shah Jamal Alam. "Risk Identification and Relapse Prediction in Lung Adenocarcinoma (LUAD)." In 2024 International Conference on Artificial Intelligence, Metaverse and Cybersecurity (ICAMAC). IEEE, 2024. https://doi.org/10.1109/icamac62387.2024.10828988.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Androni, Artemis, Christos Garoufis, Athanasia Zlatintsi, and Petros Maragos. "Feature-Level Multimodal Fusion for Relapse Detection in Patients with Psychosis." In 2025 25th International Conference on Digital Signal Processing (DSP). IEEE, 2025. https://doi.org/10.1109/dsp65409.2025.11075191.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Yasin, Sana, Imran Raza, Alice Othmani, and Syed Asad Hussain. "AI-Enabled Electroencephalogram (EEG) Analysis for Depression Relapse Detection in Quadriplegic Patients." In 2024 International Conference on Computing, Internet of Things and Microwave Systems (ICCIMS). IEEE, 2024. http://dx.doi.org/10.1109/iccims61672.2024.10690640.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Daw, S., and K. Kelly. "Relapse treatments." In ISCAYAHL 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1701866.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tent, Michiel. "A pre-relapse immune signature implicates EBV reactivation in MS relapse." In ACTRIMS Forum 2025, edited by Rachel Giles. Medicom Medical Publishers, 2025. https://doi.org/10.55788/24c5a367.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Murnane, Elizabeth L., and Scott Counts. "Unraveling abstinence and relapse." In CHI '14: CHI Conference on Human Factors in Computing Systems. ACM, 2014. http://dx.doi.org/10.1145/2556288.2557145.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Alrahamneh, H., A. E. Orellana, and A. Arzabala. "Chronic Eosinophilic Pneumonia Relapse." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3229.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cruz, Marta Arnáez De La, Victor Lago, Sandra Florez Herrero, et al. "#618 Multicenter analysis of the relapse pattern and treatment in relapsed endometrial cancer." In ESGO 2023 Congress. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/ijgc-2023-esgo.354.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Yang, Zhou, Long H. Nguyen, and Fang Jin. "Opioid relapse prediction with GAN." In ASONAM '19: International Conference on Advances in Social Networks Analysis and Mining. ACM, 2019. http://dx.doi.org/10.1145/3341161.3342951.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Relapse"

1

Hashim, Zia, Alok Nath, Mansi Gupta, Ajmal Khan, Ajit Kumar Jha, and Anup Kumar. Sarcoidosis Relapse: Systematic Review and Metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.8.0056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Karadeniz, Meltem. The hunt for a signature of MS relapse. Edited by Suzannah Lyons. Monash University, 2024. http://dx.doi.org/10.54377/59b7-2eef.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Conway, Terry L. Improving Navy Women's Health: Preventing Smoking Relapse After Recruit Training. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada370229.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Buckley, Jonathan D. Predicting Time-to-Relapse in Breast Cancer Using Neural Networks. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada300396.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zhou, Dongdong. Non-pharmacological interventions in relapse prevention of unipolar depression: a network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.4.0072.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hanlon, Alexandra L. Hierarchical Nonlinear Mixed Effect Modeling: Defining Post-radiation Therapy Relapse in Prostate Cancer Patients. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada432448.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hanlon, Alexandra L. Hierarchical Nonlinear Mixed Effect Modeling: Defining Post-Radiation Therapy Relapse in Prostate Cancer Patients. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada413285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hanlon, Alexandra L. Hierarchical Nonlinear Mixed Effects Modeling: Defining Post-Radiation Therapy Relapse in Prostate Cancer Patients. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada418391.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Boyland, Latoria, Kara Darretta, and Keevia Porter. Long-Acting Antipsychotic Injectables vs. Oral Antipsychotics: Comparing Compliance, Relapse, and Re-Hospitalization Rates. University of Tennessee Health Science Center, 2022. http://dx.doi.org/10.21007/con.dnp.2022.0037.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sobell, Mark B., Alan Peterson, Linda C. Sobell, Christopher Hunter, and Christine Hunter. Facilitating Smoking Cessation and Preventing Relapse in Primary Care: Minimizing Weight Gain by Reducing Alcohol. Defense Technical Information Center, 2009. http://dx.doi.org/10.21236/ada500902.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!